These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 7412965)

  • 21. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of overweight and obesity in calcium oxalate stone formation.
    Siener R; Glatz S; Nicolay C; Hesse A
    Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies of dietary influence on urinary oxalate in calcium oxalate stone formers].
    Arima K
    Hinyokika Kiyo; 1983 Dec; 29(12):1587-603. PubMed ID: 6687143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA; Hennequin C; Lacour B; Daudon M
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of oral pyridoxine upon plasma and 24-hour urinary oxalate levels in normal subjects and stone formers with idiopathic hypercalciuria.
    Edwards P; Nemat S; Rose GA
    Urol Res; 1990; 18(6):393-6. PubMed ID: 2100414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
    Tefekli A; Esen T; Ziylan O; Erol B; Armagan A; Ander H; Akinci M
    Urol Int; 2003; 70(4):273-7. PubMed ID: 12740490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The etiology of urolithiasis in Udaipur (western part of India).
    Pendse AK; Singh PP
    Urol Res; 1986; 14(2):59-62. PubMed ID: 3727215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
    Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
    J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary risk factors in calcium oxalate stone disease: comparison of men and women.
    Ryall RL; Harnett RM; Hibberd CM; Mazzachi BC; Mazzachi RD; Marshall VR
    Br J Urol; 1987 Dec; 60(6):480-8. PubMed ID: 3427328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of long-term rice bran treatment on stone recurrence in hypercalciuric patients.
    Ebisuno S; Morimoto S; Yasukawa S; Ohkawa T
    Br J Urol; 1991 Mar; 67(3):237-40. PubMed ID: 1902388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children.
    Milosević D; Batinić D; Konjevoda P; Blau N; Stambuk N; Nizić L; Vrljicak K; Batinić D
    J Chem Inf Comput Sci; 2003; 43(6):1844-7. PubMed ID: 14632431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The variability and dietary dependence of urinary oxalate excretion in recurrent calcium stone formers.
    Brown JM; Stratmann G; Cowley DM; Mottram BM; Chalmers AH
    Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():385-90. PubMed ID: 3662388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of the 24-hour urine analysis in the assessment of stone-formers attending a general hospital outpatient clinic.
    Ryall RL; Marshall VR
    Br J Urol; 1983 Feb; 55(1):1-5. PubMed ID: 6824849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New aspects in the treatment of oxalate lithiasis (author's transl)].
    Hautmann R; Hering FJ; Terhorst B; Lutzeyer W
    Urologe A; 1976 Jul; 15(4):148-52. PubMed ID: 960323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation.
    Mikami K; Akakura K; Takei K; Ueda T; Mizoguchi K; Noda M; Miyake M; Ito H
    Int J Urol; 2003 Jun; 10(6):293-6. PubMed ID: 12757596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical role of oxalate restriction in association with calcium restriction to decrease the probability of being a stone former: insufficient effect in idiopathic hypercalciuria.
    Bataille P; Pruna A; Gregoire I; Charransol G; de Fremont JF; Coevoet B; Galy C; Fournier A
    Proc Eur Dial Transplant Assoc; 1983; 20():401-6. PubMed ID: 6657662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Incidence of hyperoxaluria in idiopathic calcium nephrolithiasis].
    Jaeger P; Portmann L; Bugnon JM; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1795-8. PubMed ID: 7178877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors.
    Laminski NA; Meyers AM; Kruger M; Sonnekus MI; Margolius LP
    Br J Urol; 1991 Nov; 68(5):454-8. PubMed ID: 1747716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evening urinary oxalate excretion in stone formers.
    Banks JG; Sullivan M; Hargreave TB
    Br J Urol; 1979 Oct; 51(5):349-51. PubMed ID: 533589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical studies on recurrence of urolithiasis. (2) Hypercalciuria and recurrence of urolithiasis].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Nov; 33(11):1766-71. PubMed ID: 3445858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.